Molecular Mechanisms and Genetics of Oxidative Stress in Alzheimer’s Disease
Open accessAbstract
Alzheimer's disease is the most common neurodegenerative disorder that can cause dementia in elderly over 60 years of age. One of the disease hallmarks is oxidative stress which interconnects with other processes such as amyloid-β deposition, tau hyperphosphorylation, and tangle formation. This review discusses current thoughts on molecular mechanisms that may relate oxidative stress to Alzheimer's disease and identifies genetic factors observed from in vitro, in vivo, and clinical studies that may be associated with Alzheimer's disease-related oxidative stress.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Oxidative damage has been implicated in all major neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, and multiple sclerosis.
“Oxidative damage has been implicated in all major neurodegenerative diseases including Alzheimer’s disease (AD) [108,109], Parkinson’s disease (PD) [110,111], Huntington’s disease (HD) [112,113], amyotrophic lateral sclerosis (ALS) [114], and multiple sclerosis (MS) [115].”
From Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease (2022) · cites this paper as [109]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769 · cited 1× · see citing works
“More specifically, soluble SDS-stable dimers, extracted from AD brains [390], up to 56 kDa soluble A assemblies that are capable of inducing cognitive impairment in Tg2576 mice [391] have been identified as potential toxic species acting upon AD progress.”
BackgroundRetractedThe Occurrence of Sleep-Disordered Breathing among Middle-Aged Adults
Young, T., Palta, M., Dempsey, J., Skatrud, J., Weber, S., & Badr, S. (1993) · New England Journal of Medicine · doi:10.1056/nejm199304293281704 · Cited by 10,183 · cited 1× · see citing works
“positively correlates with aging [202, 203], and 845 treatment of sleep apnea slows down the rate of 846 cognitive decline in patients diagnosed with mild847 to-moderate AD [201].”
BackgroundCorder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429 · cited 1× · see citing works
“Carriers of the 4-allele have an increased risk of developing AD [236] as well as a decreased age of AD onset [237] compared to non- 4 carriers.”
BackgroundAkt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 6,535 · cited 1× · see citing works
“One of the molecular models by which secreted Klotho has been suggested to regulate oxidative stress includes the insulin/IGF1 growth signaling pathway [357].”
BackgroundWang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212 · cited 2× · see citing works
“Importantly, this factor plays a crucial role in the regulation of oxygen homeostasis and the expression and stability of one of the HIF1 domains is regulated by oxygen levels [205, 209, 210].”
BackgroundJaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535 · cited 2× · see citing works
“Importantly, this factor plays a crucial role in the regulation of oxygen homeostasis and the expression and stability of one of the HIF1 domains is regulated by oxygen levels [205, 209, 210].”
BackgroundThe tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180 · see citing works
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735 · cited 2× · see citing works
“Importantly, this factor plays a crucial role in the regulation of oxygen homeostasis and the expression and stability of one of the HIF1 domains is regulated by oxygen levels [205, 209, 210].”
BackgroundStrittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268 · see citing works
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064 · cited 1× · see citing works
“Generally, experimental studies indicate that particularly the intermediate soluble aggregated forms of A are highly toxic and these species are commonly referred to as oligomers or pre- or protofibrils [388, 389].”
BackgroundItoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999 · see citing works
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837 · cited 2× · see citing works
“model which could be genetically rescued by exoge1384 nous expression of klotho cDNA [346].”
BackgroundSchreck, R., RIEBER, P., & Baeuerle, P. A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07761.x · Cited by 3,816 · cited 5× · see citing works
“The redox state regulates activation and nuclear translocation of NFκB [180], and, as such, ROS was found to induce phosphorylation of IκB via activation of responsible kinases [181, 182].”
BackgroundInfluentialItoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., & Yamamoto, M. (1999) · Genes & Development · doi:10.1101/gad.13.1.76 · Cited by 3,634 · cited 1× · see citing works
“652 In the absence of oxidative stress, Nrf2 is transcrip653 tionally inactive as its activity is repressed by Keap1 654 [154].”
BackgroundEpstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333 · see citing works
Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326 · see citing works
Cloning and characterization of a mammalian proton-coupled metal-ion transporter
Gunshin, H., Mackenzie, B., Berger, U. V., Gunshin, Y., Romero, M. F., Boron, W. F., Nussberger, S., Gollan, J. L., & Hediger, M. A. (1997) · Nature · doi:10.1038/41343 · Cited by 3,166 · see citing works
Scheltens, P., Blennow, K., Breteler, M. M. B., de Strooper, B., Frisoni, G. B., Salloway, S., & Van der Flier, W. M. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01124-1 · Cited by 3,125 · see citing works
A protein factor essential for microtubule assembly
Weingarten, M. D., Lockwood, A. H., Hwo, S. Y., & Kirschner, M. W. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.5.1858 · Cited by 3,089 · cited 2× · see citing works
“APP23 transgenic mice show methionine oxidized forms of A 1-40 [64] and methionine oxidized A is also abundantly detected in AD patient brains [38, 63, 64].”
BackgroundPathways towards and Away from Alzheimer’s Disease
Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052 · cited 1× · see citing works
“Oxidative stress is a state in which either increased levels of cellular ROS are generated and/or cellular mechanisms to reduce the potentially damaging impact of ROS are of insufficient capacity [10, 11].”
BackgroundScheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599 · see citing works
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549 · see citing works
Mammalian thioredoxin is a direct inhibitor of apoptosis signal‐regulating kinase (ASK) 1
Saitoh, M., Nishitoh, H., Fujii, M., Takeda, K., Tobiume, K., Sawada, Y., Kawabata, M., Miyazono, K., & Ichijo, H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.9.2596 · Cited by 2,377 · cited 1× · see citing works
“apoptosis signal-regulating kinase-1 (Ask-1) [253].”
Baines, C. P., Kaiser, R. A., Purcell, N. H., Blair, N. S., Osinska, H., Hambleton, M. A., Brunskill, E. W., Sayen, M. R., Gottlieb, R. A., Dorn, G. W., et al. (2005) · Nature · doi:10.1038/nature03434 · Cited by 2,280 · cited 3× · see citing works
“models have shown that mPTP formation can be efficiently blocked by the addition of a cyclophilin D inhibitor, cyclosporine A (CSA) or by depletion of CypD [448, 455, 456].”
BackgroundGenome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
the European Alzheimer's Disease Initiative Investigators, Lambert, J.-C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.439 · Cited by 2,234 · see citing works
AP-1: a double-edged sword in tumorigenesis
Eferl, R., & Wagner, E. F. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1209 · Cited by 2,218 · cited 2× · see citing works
“Various cellular stress stimuli have been shown to regulate transcriptional activity of AP-1 [223].”
BackgroundCopper, iron and zinc in Alzheimer's disease senile plaques
Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., & Markesbery, W. R. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00092-6 · Cited by 2,120 · cited 21× · see citing works
“On the other hand, serum levels of Cu2+ were shown to be increased in AD patients compared to control subjects [172].”
BackgroundInfluentialCalcium - a life and death signal
Berridge, M. J., Bootman, M. D., & Lipp, P. (1998) · Nature · doi:10.1038/27094 · Cited by 2,064 · see citing works
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012 · see citing works
Regulation of antioxidant enzymes: a significant role for melatonin
Rodrı́guez, C., Mayo, J. C., Sainz, R. M., Antolı́n, I., Herrera, F., Martı́n, V., & Reiter, R. J. (2003) · Journal of Pineal Research · doi:10.1046/j.1600-079x.2003.00092.x · Cited by 1,990 · cited 1× · see citing works
“enzymes including superoxide dismutase (SOD), 625 glutathione peroxidase (GPx), and GSH reductase 626 [143], increasing GSH synthesis [144], and inhibit627 ing prooxidant enzymes RNS, xanthine oxidase, and 628 myeloperoxidase [145].”
BackgroundAston-Jones, G., & Bloom, F. (1981) · The Journal of Neuroscience · doi:10.1523/jneurosci.01-08-00876.1981 · Cited by 1,960 · cited 1× · see citing works
“During periods of REM sleep firing rates of wake-active noradrenergic locus coeruleus neurons, cells that display high sensitivity to metabolic stress [326–328], are profoundly reduced [329].”
BackgroundSuppression of Aging in Mice by the Hormone Klotho
Kurosu, H., Yamamoto, M., Clark, J. D., Pastor, J. V., Nandi, A., Gurnani, P., McGuinness, O. P., Chikuda, H., Yamaguchi, M., Kawaguchi, H., et al. (2005) · Science · doi:10.1126/science.1112766 · Cited by 1,935 · cited 1× · see citing works
“klotho overexpressing mouse model [347].”
On the Regulation of the Blood‐supply of the Brain
Roy, C., & Sherrington, C. (1890) · The Journal of Physiology · doi:10.1113/jphysiol.1890.sp000321 · Cited by 1,834 · see citing works
Melatonin as an antioxidant: under promises but over delivers
Reiter, R. J., Mayo, J. C., Tan, D. X., Sainz, R. M., Alatorre-Jiménez, M. A., & Qin, L. (2016) · Journal of Pineal Research · doi:10.1111/jpi.12360 · Cited by 1,741 · cited 1× · see citing works
“antioxidant activity, either directly by scavenging a 621 variety of free radicals including hydroxyl, peroxyl, 622 superoxide, peroxide and peroxynitrite (ONOO−) 623 [141, 142], or indirectly by inducing antioxidant 624”
BackgroundDuring autophagy mitochondria elongate, are spared from degradation and sustain cell viability
Gomes, L. C., Benedetto, G. D., & Scorrano, L. (2011) · Nature Cell Biology · doi:10.1038/ncb2220 · Cited by 1,735 · cited 1× · see citing works
“The mitochondrial fission process relies on dynamin related protein 1 (Drp1) and mitochondrial fission protein 1 (Fis1) [121, 122].”
BackgroundMop3 is an essential component of the master circadian pacemaker in mammals.
Bunger, M. K., Wilsbacher, L. D., Moran, S. M., Clendenin, C., Radcliffe, L. A., Hogenesch, J. B., Simon, M. C., Takahashi, J. S., & Bradfield, C. A. (2000) · Cell · doi:10.1016/s0092-8674(00)00205-1 · Cited by 1,621 · cited 1× · see citing works
“Mice generated with a deletion of Bmal1 1344 demonstrated increased systemic [337, 339] and low 1345 levels of brain oxidative stress [340] mediated by 1346 a disturbance of its transcriptional targets, includ1347 ing Period Circadian Regulator 2 (Per2) and albumin 1348 D-element binding protein (Dbp) [341] as well as…”
BackgroundNeeper, M. P., Schmidt, A. M., Brett, J., Yan, S. D., Wang, F., Pan, Y., Elliston, K. O., Stern, D., & SHAW, A. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42138-2 · Cited by 1,542 · cited 1× · see citing works
“RAGE is a transmembrane receptor widely expressed in all tissue types including the brain [420, 421].”
BackgroundRapid induction of Alzheimer A beta amyloid formation by zinc
Bush, A., Pettingell, W., Multhaup, G., d Paradis, M., Vonsattel, J., Gusella, J., Beyreuther, K., Masters, C., & Tanzi, R. (1994) · Science · doi:10.1126/science.8073293 · Cited by 1,522 · cited 1× · see citing works
“act with A in vitro [174], metal ion dyshomeostasis 716 has been postulated as potential mechanism by which 717 AD pathology may be modulated.”
BackgroundTwo amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507 · cited 1× · see citing works
“ory deficits and deposition of A into plaques [277].”
BackgroundSuzuki, N., Cheung, T. T., Cai, X.-D., Odaka, A., Otvos, L., Eckman, C., Golde, T. E., & Younkin, S. G. (1994) · Science · doi:10.1126/science.8191290 · Cited by 1,471 · see citing works
Rushmore, T. H., Morton, M. R., & Pickett, C. B. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99004-6 · Cited by 1,464 · cited 1× · see citing works
“promotor element present on antioxidant genes [150].”
Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1
Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C.-M., Pérez‐Tur, J., Hutton, M., Buée, L., Harigaya, Y., Yager, D., et al. (1996) · Nature · doi:10.1038/383710a0 · Cited by 1,453 · see citing works
Reactive Oxygen Species (Ros-Induced) Ros Release
Zorov, D. B., Filburn, C. R., Klotz, L.-O., Zweier, J. L., & Sollott, S. J. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1001 · Cited by 1,412 · cited 1× · see citing works
“Moreover, cytosolic ROS was observed to induce signals leading to mPTP opening resulting in further ROS release and this phenomenon is referred to as “ROS-induced ROS release (RIRR)” [460].”
BackgroundDURÁN, J., ESNAOLA, S., RUBIO, R., & IZTUETA, Á. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.3.2005065 · Cited by 1,407 · cited 1× · see citing works
“positively correlates with aging [202, 203], and 845 treatment of sleep apnea slows down the rate of 846 cognitive decline in patients diagnosed with mild847 to-moderate AD [201].”
BackgroundOxidative stress and mitochondrial dysfunction in Alzheimer’s disease
Wang, X., Wang, W., Li, L., Perry, G., Lee, H.-G., & Zhu, X. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.10.015 · Cited by 1,357 · cited 1× · see citing works
“In neuroblastoma N2a and SH-SY5Y cells knockdown of CLU by short hairpin RNA interference was found to down-regulate antioxidant capacity [233].”
BackgroundIron accumulation in Alzheimer disease is a source of redox-generated free radicals
Smith, M. A., Harris, P. L. R., Sayre, L. M., & Perry, G. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9866 · Cited by 1,357 · see citing works
Roizen, N., & Patterson, D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12987-x · Cited by 1,333 · cited 21× · see citing works
“Using p50 and HO1, it was observed that the spatial link found between A deposits and induction of cellular ROS is not limited to CSF residing neurons, but this observation extends to endothelial and smooth muscle cells in cerebral blood vessels.”
BackgroundInfluentialCalorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation
Qiu, X., Brown, K., Hirschey, M. D., Verdin, E., & Chen, D. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.11.015 · Cited by 1,310 · cited 2× · see citing works
“NAD+-dependent deacetylase SirT3 is an important regulator of energy production and redox response by reduction of GSH [331, 332], mediating the upregulation of SOD2 and catalase [333], and activation of SOD2 [334].”
BackgroundABAD Directly Links Aß to Mitochondrial Toxicity in Alzheimer's Disease
Lustbader, J. W., Cirilli, M., Lin, C., Xu, H. W., Takuma, K., Wang, N., Caspersen, C., Chen, X., Pollak, S., Chaney, M., et al. (2004) · Science · doi:10.1126/science.1091230 · Cited by 1,303 · see citing works
Activation of Mitogen-activated Protein Kinase by H2O2
Guyton, K. Z., Liu, Y., Gorospe, M., Xu, Q., & Holbrook, N. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.8.4138 · Cited by 1,212 · see citing works
Kondratov, R. V., Kondratova, A. A., Gorbacheva, V. Y., Vykhovanets, O. V., & Antoch, M. P. (2006) · Genes & Development · doi:10.1101/gad.1432206 · Cited by 1,188 · cited 1× · see citing works
“demonstrated increased systemic [337, 339] and low”
Baeuerle, P. A., & Baltimore, D. (1988) · Cell · doi:10.1016/0092-8674(88)90382-0 · Cited by 1,166 · see citing works
Someya, S., Yu, W., Hallows, W. C., Xu, J., Vann, J. M., Leeuwenburgh, C., Tanokura, M., Denu, J. M., & Prolla, T. A. (2010) · Cell · doi:10.1016/j.cell.2010.10.002 · Cited by 1,150 · cited 16× · see citing works
“A study involving 74 human subjects demonstrated that GSH levels of autopsied brains did not significantly decrease with aging [128].”
BackgroundInfluentialCutler, R. G., Kelly, J., Storie, K., Pedersen, W. A., Tammara, A., Hatanpaa, K. J., Troncoso, J. C., & Mattson, M. P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305799101 · Cited by 1,135 · cited 1× · see citing works
“Analysis of lipid rafts in AD brain tissue samples showed that increased levels of membrane-associated oxidative stress correlated with accumulation of cholesterol and ceramides into clustered microdomains which could be prevented by the antioxidant vitamin E and ceramide inhibitors [26].”
BackgroundApolipoprotein E polymorphism and Alzheimer's disease
Poirier, J., Bertrand, P., Poirier, J., Kogan, S., Gauthier, S., Poirier, J., Gauthier, S., Davignon, J., Bouthillier, D., & Davignon, J. (1993) · The Lancet · doi:10.1016/0140-6736(93)91705-q · Cited by 1,108 · see citing works
The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore
Kokoszka, J. E., Waymire, K. G., Levy, S. E., Sligh, J. E., Cai, J., Jones, D. P., MacGregor, G. R., & Wallace, D. C. (2004) · Nature · doi:10.1038/nature02229 · Cited by 1,086 · see citing works
Hensley, K., Carney, J. M., Mattson, M. P., Aksenova, M., Harris, M., Wu, J. F., Floyd, R. A., & Butterfield, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3270 · Cited by 1,086 · cited 1× · see citing works
“which, in turn, can result in radical generation [382, 383] although this hypothesis has not been experimentally verified.”
BackgroundStructure Elucidation of a Senescence Cross-Link from Human Extracellular Matrix
Sell, D. R., & Monnier, V. M. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)88225-8 · Cited by 1,082 · see citing works
Gong, Y., Chang, L., Viola, K. L., Lacor, P. N., Lambert, M. P., Finch, C. E., Krafft, G. A., & Klein, W. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834302100 · Cited by 1,061 · cited 1× · see citing works
“Generally, experimental studies indicate that particularly the intermediate soluble aggregated forms of A are highly toxic and these species are commonly referred to as oligomers or pre- or protofibrils [388, 389].”
BackgroundRudic, R. D., McNamara, P., Curtis, A.-M., Boston, R. C., Panda, S., Hogenesch, J. B., & FitzGerald, G. A. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020377 · Cited by 1,059 · see citing works
Regulation of clock and NPAS2 DNA binding by the redox state of NAD cofactors
Rutter, J., Reick, M., Wu, L. C., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1060698 · Cited by 1,059 · cited 2× · see citing works
“Both SirT3 and BMAL1 levels are tightly regulated by circadian rhythmicity of oxidoreductase factor nicotinamide adenine dinucleotide (NAD+) [342], while, in turn cellular redox status affects the activity of clock transcription factors [335].”
BackgroundSayre, L., Zelasko, D. A., Harris, P. L. R., Perry, G., Salomon, R. G., & Smith, M. A. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052092.x · Cited by 1,032 · see citing works
Atwood, C. S., Moir, R. D., Huang, X., Scarpa, R. C., Bacarra, N. M. E., Romano, D. M., Hartshorn, M. A., Tanzi, R. E., & Bush, A. I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.12817 · Cited by 1,009 · see citing works
Melatonin: an ancient molecule that makes oxygen metabolically tolerable
Manchester, L. C., Coto‐Montes, A. M., Boga, J. A., Andersen, L. P. H., Zhou, Z., Galano, A., Vriend, J. P., Tan, D. X., & Reiter, R. J. (2015) · Journal of Pineal Research · doi:10.1111/jpi.12267 · Cited by 954 · cited 1× · see citing works
“antioxidant activity, either directly by scavenging a 621 variety of free radicals including hydroxyl, peroxyl, 622 superoxide, peroxide and peroxynitrite (ONOO−) 623 [141, 142], or indirectly by inducing antioxidant 624”
BackgroundYao, J., Irwin, R. W., Zhao, L., Nilsen, J., Hamilton, R. T., & Brinton, R. D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903563106 · Cited by 940 · cited 1× · see citing works
“Related to this, pre-symptomatic AD has been associated with mitochondrial deficiency resulting in disturbed bioenergetics [8].”
BackgroundNeuronal calcium mishandling and the pathogenesis of Alzheimer's disease
Bezprozvanny, I., & Mattson, M. P. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.06.005 · Cited by 938 · cited 1× · see citing works
“Release of Ca2+ from the extracellular pools into the cell is mediated by factors such as voltage-gated Ca2+ channels, N-methylo-Daspartate (NMDA) receptors and transient receptor potential channels while intracellular Ca2+, stored in the endoplasmic reticulum, is released via the inositol triphosphate receptor (Ins[1…”
BackgroundDu, H., Guo, L., Fang, F., Chen, D., Sosunov, A. A., McKhann, G. M., Yan, Y., Wang, C., Zhang, H., Molkentin, J. D., et al. (2008) · Nature Medicine · doi:10.1038/nm.1868 · Cited by 935 · see citing works
Advanced Glycosylation End Products in Patients with Diabetic Nephropathy
Makita, Z., Radoff, S., Rayfield, E. J., Yang, Z. H., Skolnik, E. Y., DELANEY, V. B., Friedman, E. A., Cerami, A., & Vlassara, H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109193251202 · Cited by 917 · cited 1× · see citing works
“AGEs are the product of non-enzymatic aldose-mediated glycated or oxidized proteins [422], and accumulation of AGEs was shown to be agingrelated [423, 424] and accelerates in conditions such as diabetes [425].”
BackgroundPeroxiredoxins are conserved markers of circadian rhythms
Edgar, R. S., Green, E. W., Zhao, Y., Gerben Van Ooijen, A., Olmedo, M., Qin, X., Xu, Y. Q., Pan, M., Valekunja, U. K., Feeney, K. A., et al. (2012) · Nature · doi:10.1038/nature11088 · Cited by 915 · cited 1× · see citing works
“On the other hand, brain and peripheral tissues were shown to differ in their peroxiredoxin oxidation rhythms [324] as well as in other clock components [325].”
BackgroundMiyata, M., & Smith, J. D. (1996) · Nature Genetics · doi:10.1038/ng0996-55 · Cited by 889 · cited 1× · see citing works
“ApoE was demonstrated to act, directly or indirectly, as an antioxidant against hydrogen peroxide-induced cytotoxicity in a B12 ApoE expressing cell line [250].”
BackgroundStamer, K., Vogel, R., Thies, E., Mandelkow, E., & Mandelkow, E.-M. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200108057 · Cited by 885 · cited 23× · see citing works
“In another study, methionine 35 of synthesized A 1-42 was oxidized by exposure to H2O2 and oxidation was validated using mass spectrometry.”
BackgroundInfluentialShah, K., Kumar, R. G., Verma, S., & Dubey, R. S. (2001) · Plant Science · doi:10.1016/s0168-9452(01)00517-9 · Cited by 878 · cited 1× · see citing works
“These ROS, in turn, have been related to membrane damage, cytoskeletal alterations, and cell death [9].”
BackgroundMa, J., Yee, A., Brewer, H. B., Das, S., & Potter, H. (1994) · Nature · doi:10.1038/372092a0 · Cited by 871 · cited 1× · see citing works
“The pathogenic origins of ApoE4 have been studied to great length and indicate that ApoE4 is involved in processes such as aggregation and clearance of A [240, 241], mitochondrial dysfunction, and impairment of calcium [242, 243] or cellular iron homeostasis [244], and ApoE4 affects synaptic architecture and functioni…”
BackgroundGlutathione and Related γ-Glutamyl Compounds: Biosynthesis and Utilization
Meister, A., & Tate, S. S. (1976) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.45.070176.003015 · Cited by 839 · cited 6× · see citing works
“Oxidative stress induces the expression of the NADPH-dependent enzyme glutathione reductase, which reverts oxidized GSSG to its reduced form GSH [129].”
BackgroundInfluentialMańczak, M., Calkins, M. J., & Reddy, P. H. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr139 · Cited by 830 · cited 1× · see citing works
“Further, AD mouse models and AD patients show the presence of multiple small mitochondria and exaggerated mitochondrial division [120] suggesting that the mitochondrial fission process is altered in AD.”
BackgroundZhong, H., Suyang, H., Erdjument‐Bromage, H., Tempst, P., & Ghosh, S. (1997) · Cell · doi:10.1016/s0092-8674(00)80222-6 · Cited by 828 · see citing works
Schinzel, A. C., Takeuchi, O., Huang, Z., Fisher, J. K., Zhou, Z., Rubens, J., Hetz, C., Danial, N. N., Moskowitz, M. A., & Korsmeyer, S. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505294102 · Cited by 820 · see citing works
Properties of the Permeability Transition Pore in Mitochondria Devoid of Cyclophilin D
Basso, E., Fante, L., Fowlkes, J., Petronilli, V., Forte, M. A., & Bernardi, P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500089200 · Cited by 808 · see citing works
Advanced glycation end products contribute to amyloidosis in Alzheimer disease
Vitek, M. P., Bhattacharya, K., Glendening, J. M., Stopa, E., Vlassara, H., Bucala, R., Manogue, K., & Cerami, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4766 · Cited by 806 · see citing works
Shih, A. Y., Johnson, D. A., Wong, G., Kraft, A. D., Jiang, L., Erb, H., Johnson, J. A., & Murphy, T. H. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-08-03394.2003 · Cited by 786 · see citing works
Brett, J., Schmidt, A. M., Yan, S. D., Zou, Y. S., Weidman, E., Pinsky, D. J., Nowygrod, R., Neeper, M. P., Przysiecki, C. T., & SHAW, A. R. (1993) · PubMed Central · Cited by 776 · see citing works
Suh, J. H., Shenvi, S. V., Dixon, B. M., Liu, H., Jaiswal, A. K., Liu, R.-M., & Hagen, T. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400282101 · Cited by 774 · see citing works
apoE isoform–specific disruption of amyloid β peptide clearance from mouse brain
Deane, R., Sagare, A., Hamm, K., Parisi, M., Lane, S., Finn, M. B., Holtzman, D. M., & Zlokovic, B. V. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36663 · Cited by 771 · cited 1× · see citing works
“The pathogenic origins of ApoE4 have been studied to great length and indicate that ApoE4 is involved in processes such as aggregation and clearance of A [240, 241], mitochondrial dysfunction, and impairment of calcium [242, 243] or cellular iron homeostasis [244], and ApoE4 affects synaptic architecture and functioni…”
BackgroundRNA Oxidation Is a Prominent Feature of Vulnerable Neurons in Alzheimer’s Disease
Nunomura, A., Perry, G., Pappolla, M., Wade, R., Hirai, K., Chiba, S., & Smith, M. A. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-06-01959.1999 · Cited by 768 · cited 1× · see citing works
“brain tissues of patients affected by AD [36].”
BackgroundOxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain
Mecocci, P., MacGarvey, U., Kaufman, A. E., Koontz, D., Shoffner, J. M., Wallace, D. C., & Beal, M. F. (1993) · Annals of Neurology · doi:10.1002/ana.410340416 · Cited by 757 · see citing works
Ichas, F., Jouaville, L. S., & Mazat, J. (1997) · Cell · doi:10.1016/s0092-8674(00)80301-3 · Cited by 754 · see citing works
Brain insulin and insulin receptors in aging and sporadic Alzheimer’s disease
Frölich, L., Blum-Degen, D., Bernstein, H.-G., Engelsberger, S., Humrich, J., Laufer, S., Muschner, D., Thalheimer, A., Türk, A., Hoyer, S., et al. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050068 · Cited by 748 · cited 1× · see citing works
“1676 Upon aging, glucose metabolism derails progres1677 sively as a result of changes in brain insulin [404], 1678 and cortisol [405] levels.”
BackgroundSleep Quality and Preclinical Alzheimer Disease
Ju, Y.-E. S., McLeland, J. S., Toedebusch, C. D., Xiong, C., Fagan, A. M., Duntley, S. P., Morris, J. C., & Holtzman, D. M. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.2334 · Cited by 744 · see citing works
Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro
Busciglio, J., & Yankner, B. A. (1995) · Nature · doi:10.1038/378776a0 · Cited by 741 · cited 1× · see citing works
“Programmed cell death could be rescued by administration of free radical scavengers including vitamin E, and N-tert-butyl-2sulphophenylnitrone [263] but dietary parameters did not alleviate oxidative stress biomarkers in young adult DS patients [20].”
BackgroundRoher, A. E., Lowenson, J. D., Clarke, S., Woods, A. S., Cotter, R. J., Gowing, E., & Ball, M. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10836 · Cited by 740 · see citing works
The Role of Amyloid-β Oligomers in Toxicity, Propagation, and Immunotherapy
Sengupta, U., Nilson, A. N., & Kayed, R. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.03.035 · Cited by 740 · see citing works
Wang, X., Martindale, J. L., Liu, Y., & Holbrook, N. J. (1998) · Biochemical Journal · doi:10.1042/bj3330291 · Cited by 735 · cited 1× · see citing works
“More1249 over, members of the SAPK family were also found to 1250 be upregulated in AD patient brains [30, 313] and are 1251 activated by various stress signals including oxida1252 tive stress [314, 315].”
BackgroundMitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology
Moreira, P. I., Carvalho, C., Zhu, X., Smith, M. A., & Perry, G. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.10.006 · Cited by 734 · see citing works
Ide, T., Tsutsui, H., Hayashidani, S., Kang, D., Suematsu, N., Nakamura, K., Utsumi, H., Hamasaki, N., & Takeshita, A. (2001) · Circulation Research · doi:10.1161/01.res.88.5.529 · Cited by 733 · cited 1× · see citing works
“myocardial infarction [18], sickle cell disease [19],”
Regulation of hypoxia-inducible factor-1α by NF-κB
van Uden, P., Kenneth, N. S., & Rocha, S. (2008) · Biochemical Journal · doi:10.1042/bj20080476 · Cited by 729 · cited 1× · see citing works
“NF-kB has been identified as important regulator of HIF-1 expression [295].”
BackgroundElevated β-secretase expression and enzymatic activity detected in sporadic Alzheimer disease
Yang, L.-B., Lindholm, K., Yan, R., Citron, M., Xia, W., Yang, X.-L., Beach, T., Sue, L., Wong, P., Price, D., et al. (2003) · Nature Medicine · doi:10.1038/nm0103-3 · Cited by 729 · cited 1× · see citing works
“P38MAPK was also reported to be active and identified in A deposits of A PP tg mice [310].”
BackgroundRegulation of Oxidative Stress by the Anti-aging Hormone Klotho*♦
Yamamoto, M., Clark, J. D., Pastor, J. V., Gurnani, P., Nandi, A., Kurosu, H., Miyoshi, M., Ogawa, Y., Castrillón, D. H., Rosenblatt, K. P., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509039200 · Cited by 724 · cited 5× · see citing works
“NAD+-dependent deacetylase SirT3 is an important regulator of energy production and redox response by reduction of GSH [331, 332], mediating the upregulation of SOD2 and catalase [333], and activation of SOD2 [334].”
BackgroundResultInfluentialβ-Secretase Protein and Activity Are Increased in the Neocortex in Alzheimer Disease
Fukumoto, H. (2002) · Archives of Neurology · doi:10.1001/archneur.59.9.1381 · Cited by 695 · see citing works
Tu, H., Nelson, O. L., Bezprozvanny, A., Wang, Z., Lee, S.-F., Hao, Y.-H., Serneels, L., Strooper, B. D., Yu, G., & Борисович, Б. И. (2006) · Cell · doi:10.1016/j.cell.2006.06.059 · Cited by 691 · cited 1× · see citing works
“For example, whereas wild type presenilin was reported to form Ca2+ permeable channels allowing Ca2+ leakage from the endoplasmic reticulum [438, 439], some, but not all FAD related mutations in Psen1 and 2, show deficiencies in Ca2+ leak function in a mouse embryonic fibroblast model, primary fibroblasts obtained fro…”
BackgroundOxidative stress in brain aging, neurodegenerative and vascular diseases: An overview
Mariani, E., Polidori, M. C., Cherubini, A., & Mecocci, P. (2005) · Journal of Chromatography B · doi:10.1016/j.jchromb.2005.04.023 · Cited by 682 · see citing works
Toward clinical application of the Keap1-Nrf2 pathway
Suzuki, T., Motohashi, H., & Yamamoto, M. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.04.005 · Cited by 680 · see citing works
Matsumura, Y., Aizawa, H., Shiraki-Iida, T., Nagai, R., Kuro‐o, M., & Nabeshima, Y.-I. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.8019 · Cited by 677 · see citing works
Petronilli, V., Miotto, G., Canton, M., Brini, M., Colonna, R., Bernardi, P., & Lisa, F. D. (1999) · Biophysical Journal · doi:10.1016/s0006-3495(99)77239-5 · Cited by 677 · see citing works
Hardeland, R. (2005) · Endocrine · doi:10.1385/endo:27:2:119 · Cited by 670 · see citing works
Circadian Clock NAD + Cycle Drives Mitochondrial Oxidative Metabolism in Mice
Peek, C. B., Affinati, A. H., Ramsey, K. M., Kuo, H.-Y., Yu, W., Sena, L. A., Ilkayeva, O., Marcheva, B., Kobayashi, Y., Omura, C., et al. (2013) · Science · doi:10.1126/science.1243417 · Cited by 658 · see citing works
Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro.
Toledano, M. B., & Leonard, W. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.10.4328 · Cited by 657 · cited 6× · see citing works
“cation of NFκB [180], and, as such, ROS was found”
BackgroundInfluentialEffect of Lipid Peroxidation on the Properties of Lipid Bilayers: A Molecular Dynamics Study
Wong-ekkabut, J., Xu, Z., Triampo, W., Tang, I., Tieleman, D. P., & Monticelli, L. (2007) · Biophysical Journal · doi:10.1529/biophysj.107.112565 · Cited by 645 · see citing works
Atwood, C. S., Scarpa, R. C., Huang, X., Moir, R. D., Jones, W. D., Fairlie, D. P., Tanzi, R. E., & Bush, A. I. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751219.x · Cited by 641 · see citing works
Alterations in the circadian rest-activity rhythm in aging and Alzheimer's disease
Witting, W., Kwa, I. H., Eikelenboom, P., Mirmiran, M., & Swaab, D. F. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90523-5 · Cited by 621 · see citing works
Kuchibhotla, K. V., Goldman, S. T., Lattarulo, C. R., Wu, H.-Y., Hyman, B. T., & Bacskai, B. J. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.008 · Cited by 614 · cited 1× · see citing works
“6 packaged into an adeno-associated virus (AAV2) and expressed in the brains of adult transgenic APP/PS1 mice showed that calcium overloaded neurites in living animals were more likely to be located in close proximity (<25 m) of a plaque [175].”
BackgroundThe neurobiology of glia in the context of water and ion homeostasis
Simard, M. F., & Nedergaard, M. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.09.053 · Cited by 607 · cited 1× · see citing works
“which subsequently binds to purine receptors on 1864 the membrane of adjacent astrocytes [441].”
BackgroundOxidative stress in the progression of Alzheimer disease in the frontal cortex
Ansari, M. A., & Scheff, S. W. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181cb5af4 · Cited by 605 · cited 2× · see citing works
“corroborates the thought that oxidative stress is an 799 early stage pathological feature of AD [188].”
BackgroundA signalling role for 4‐hydroxy‐2‐nonenal in regulation of mitochondrial uncoupling
Echtay, K. S., Esteves, T. C., Pakay, J. L., Jekabsons, M. B., Lambert, A. J., Portero‐Otín, M., Pamplona, R., Vidal‐Puig, A. J., Wang, S., Roebuck, S. J., et al. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg412 · Cited by 597 · cited 1× · see citing works
“Interestingly, HNE levels were observed to be proportional to the extent of neuronal lesions [28, 29].”
BackgroundHalestrap, A. P., Woodfield, K.-Y., & Connern, C. P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3346 · Cited by 592 · cited 1× · see citing works
“models have shown that mPTP formation can be efficiently blocked by the addition of a cyclophilin D inhibitor, cyclosporine A (CSA) or by depletion of CypD [448, 455, 456].”
BackgroundMetalloenzyme-like Activity of Alzheimer's Disease β-Amyloid
Opazo, C., Huang, X., Cherny, R. A., Moir, R. D., Roher, A. E., White, A. R., Cappai, R., Masters, C. L., Tanzi, R. E., Inestrosa, N. C., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206428200 · Cited by 580 · see citing works
Bell, E. L., Klimova, T. A., Eisenbart, J., Moraes, C. T., Murphy, M. P., Budinger, G. R. S., & Chandel, N. S. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200609074 · Cited by 568 · cited 1× · see citing works
“Hypoxic conditions are considered to raise cytosolic ROS levels and, in this way, induce the activation of HIF (reviewed in [211]) probably in a mitochondrial complex III-dependent manner [212].”
BackgroundGlycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress.
Yan, S. D., Chen, X., Schmidt, A. M., Brett, J., Godman, G., Zou, Y. S., Scott, C. W., Caputo, C., Frappier, T., & Smith, M. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7787 · Cited by 565 · cited 2× · see citing works
“Uptake of AGE-glycated tau into SH-SY5Y neuroblastoma cells was associated with malondialdehyde and HO-1 detection which was prevented by the exposure of these cells to N-acetylcysteine and probucol, two antioxidant compounds [116].”
BackgroundIncreased expression of the amyloid precursor β‐secretase in Alzheimer's disease
Holsinger, R. M. D., McLean, C. A., Beyreuther, K., Masters, C. L., & Evin, G. (2002) · Annals of Neurology · doi:10.1002/ana.10208 · Cited by 562 · see citing works
Dong, J., Atwood, C., Anderson, V. E., Siedlak, S. L., Smith, M. A., Perry, G. L., & CAREY, P. R. (2003) · Biochemistry · doi:10.1021/bi0272151 · Cited by 560 · cited 2× · see citing works
“Increased levels of oxidative stress in the brain are reflected by increased brain content of copper (Cu) and zinc (Zn), specifically in the neuropil and in AD plaques [47, 48].”
BackgroundChen, C.-D., Podvin, S., Gillespie, E., Leeman, S. E., & Abraham, C. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709805104 · Cited by 553 · cited 1× · see citing works
“The latter is released into the extracellular space upon insulin-mediated release by ADAM family members ADAM10 and ADAM17 [345].”
BackgroundMark, R. J., Pang, Z., Geddes, J. W., Uchida, K., & Mattson, M. P. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-03-01046.1997 · Cited by 551 · see citing works
Amyloid‐β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress
Smith, M. A., Hirai, K., Hsiao, K., Pappolla, M. A., Harris, P. L. R., Siedlak, S. L., Tabaton, M., & Perry, G. L. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70052212.x · Cited by 547 · see citing works
Stimulation by calcium ions of pyruvate dehydrogenase phosphate phosphatase
Denton, R. M., Randle, P. J., & Martin, B. R. (1972) · Biochemical Journal · doi:10.1042/bj1280161 · Cited by 542 · see citing works
Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau.
Greenberg, S. G., Davies, P., Schein, J., & Binder, L. I. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48531-6 · Cited by 542 · cited 1× · see citing works
“Crosslinking of tau into paired helical filaments was shown to be driven by abnormal levels of phosphorylation, or hyperphosphorylation, of tau, which renders the protein insoluble and dysfunctional [377, 378].”
BackgroundKraft, A. D., Johnson, D. A., & Johnson, J. A. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.3817-03.2004 · Cited by 541 · cited 1× · see citing works
“The neuron-glial unit, the main interaction site between neurons and cells of glial origin such as astrocytes, regulates oxidative stress levels through an intimately linked intercellular mechanism for maintaining redox homeostasis [147, 148].”
BackgroundDeibel, M. A., Ehmann, W. D., & Markesbery, W. R. (1996) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(96)00203-1 · Cited by 540 · see citing works
Cancer Chemoprevention Mechanisms Mediated Through the Keap1–Nrf2 Pathway
Hayes, J. D., McMahon, M. J., Chowdhry, S., & Dinkova‐Kostova, A. T. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3221 · Cited by 540 · see citing works
In Situ Oxidative Catalysis by Neurofibrillary Tangles and Senile Plaques in Alzheimer’s Disease
Sayre, L. M., Perry, G. L., Harris, P. L. R., Liu, Y. A., Schubert, K. A., & Smith, M. A. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0740270.x · Cited by 538 · see citing works
Proteomic identification of nitrated proteins in Alzheimer's disease brain
Castegna, A., Thongboonkerd, V., Klein, J. B., Lynn, B. C., Markesbery, W. R., & Butterfield, D. A. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01786.x · Cited by 535 · see citing works
Kuperstein, I., Broersen, K., Benilova, I., Rozenski, J., Jonckheere, W., Debulpaep, M., Vandersteen, A., Segers‐Nolten, I., Van Der Werf, K., Subramaniam, V., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.211 · Cited by 532 · see citing works
Self-citationCortical Cytochrome Oxidase Activity Is Reduced in Alzheimer's Disease
Mutisya, E. M., Bowling, A. C., & Beal, M. F. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63062179.x · Cited by 531 · see citing works
Circadian clock proteins regulate neuronal redox homeostasis and neurodegeneration
Musiek, E. S., Lim, M. M., Yang, G., Bauer, A. Q., Qi, L., Lee, Y., Roh, J. H., Ortiz-Gonzalez, X., Dearborn, J. T., Culver, J. P., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70317 · Cited by 524 · see citing works
Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease
Srikanth, V., Maczurek, A., Phan, T., Steele, M., Westcott, B., Juskiw, D., & Münch, G. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.04.016 · Cited by 524 · cited 1× · see citing works
“The roles of RAGE and AGEs in AD pathogenesis have been covered in a number of reviews [426, 427].”
BackgroundLiu, J., Head, E., Gharib, A., Yuan, W., Ingersoll, R. T., Hagen, T. M., Cotman, C. W., & Ames, B. N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261709299 · Cited by 504 · cited 1× · see citing works
“increased in the hippocampus, cortical neurons, white matter and in the frontoparietal cortex of aged rats [37].”
BackgroundElectron transport chain defects in Alzheimer's disease brain
Parker, W. D., Parks, J. K., Filley, C. M., & Kleinschmidt-DeMasters, B. K. (1994) · Neurology · doi:10.1212/wnl.44.6.1090 · Cited by 495 · see citing works
Crompton, M., Virji, S., & Ward, J. M. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2580729.x · Cited by 492 · see citing works
Immunochemical detection of advanced glycosylation end products in vivo.
Makita, Z., Vlassara, H., Cerami, A., & Bucala, R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42741-x · Cited by 491 · cited 1× · see citing works
“AGEs are the product of non-enzymatic aldose-mediated glycated or oxidized proteins [422], and accumulation of AGEs was shown to be agingrelated [423, 424] and accelerates in conditions such as diabetes [425].”
Backgroundβ‐Amyloid inhibits integrated mitochondrial respiration and key enzyme activities
Casley, C. S., Canevari, L., Land, J. M., Clark, J. B., & Sharpe, M. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00681.x · Cited by 485 · cited 1× · see citing works
“using oxygen sensitive electrodes [419].”
Association of human aging with a functional variant of klotho
Arking, D. E., Krebsová, A., Maçek, M., Maçek, M., Arking, A., Mian, S. I., Fried, L. F., Hamosh, A., Dey, S., McIntosh, I., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022484299 · Cited by 481 · see citing works
Amyloid β Protein Enhances the Survival of Hippocampal Neurons in Vitro
Whitson, J. S., Selkoe, D. J., & Cotman, C. W. (1989) · Science · doi:10.1126/science.2928783 · Cited by 469 · cited 1× · see citing works
“Supportive of such a hypothesis is the observation that A was found to act as a neurotrophic agent selectively at low nM concentrations while at higher peptide concentrations neurotrophic functionality was abolished [363, 373, 374].”
BackgroundNäslund, J., Schierhorn, A., Hellman, U., Lannfelt, L., Roses, A. D., Tjernberg, L. O., Silberring, J., Gandy, S. E., Winblad, B., & Greengard, P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8378 · Cited by 468 · cited 2× · see citing works
“APP23 transgenic mice show methionine oxidized forms of A 1-40 [64] and methionine oxidized A is also abundantly detected in AD patient brains [38, 63, 64].”
BackgroundLe-Niculescu, H., Bonfoco, E., Kasuya, Y., Claret, F.-X., Green, D. R., & Karin, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.751 · Cited by 460 · cited 1× · see citing works
“More1249 over, members of the SAPK family were also found to 1250 be upregulated in AD patient brains [30, 313] and are 1251 activated by various stress signals including oxida1252 tive stress [314, 315].”
BackgroundNeuronal and glial calcium signaling in Alzheimer’s disease
Mattson, M. P., & Chan, S. L. (2003) · Cell Calcium · doi:10.1016/s0143-4160(03)00128-3 · Cited by 454 · see citing works
The effect of hyperoxia on superoxide production by lung submitochondrial particles
Turrens, J. F., Freeman, B. Α., Levitt, J. G., & Crapo, J. D. (1982) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(82)90518-5 · Cited by 448 · cited 1× · see citing works
“to ROS generation in rat and porcine lung [436],”
BackgroundYu, W., Dittenhafer‐Reed, K. E., & Denu, J. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.355206 · Cited by 445 · cited 16× · see citing works
“A study involving 74 human subjects demonstrated that GSH levels of autopsied brains did not significantly decrease with aging [128].”
BackgroundInfluentialKeller, J. N., Pang, Z., Geddes, J. W., Begley, J. G., Germeyer, A., Waeg, G., & Mattson, M. P. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69010273.x · Cited by 439 · see citing works
Zlokovic, B. V., Martel, C. L., Matsubara, E., McComb, J. G., Zheng, G., McCluskey, R. T., Frangione, B., & Ghiso, J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4229 · Cited by 430 · cited 1× · see citing works
“Multi-ligand receptor megalin has been identified to also act as receptor of clusterin [222].”
BackgroundAlmeida, A., Almeida, J., Bolaños, J. P., & Moncada, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261560998 · Cited by 423 · see citing works
Bergeron, M., Yu, A. Y., Solway, K., Semenza, G. L., & Sharp, F. R. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00845.x · Cited by 413 · see citing works
Presenilin clinical mutations can affect γ‐secretase activity by different mechanisms
Bentahir, M., Nyabi, O., Verhamme, J., Tolia, A., Horré, K., Wiltfang, J., Esselmann, H., & Strooper, B. D. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03578.x · Cited by 412 · cited 1× · see citing works
“ated processing of A PP in various ways [288].”
BackgroundYan, S. D., Yan, S. F., Chen, X., Fu, J., Chen, M., Kuppusamy, P., Smith, M. A., Perry, G., Godman, G. C., Nawroth, P., et al. (1995) · Nature Medicine · doi:10.1038/nm0795-693 · Cited by 406 · cited 2× · see citing works
“Instead of the uniformly elongated mitochondrial morphology observed in wild type mice, human AD brain and hippocampal mitochondria in mice carrying mutations for presenilin-1 (psen1), A PP, and tau, have an ovoid or teardrop profile [115].”
BackgroundThambisetty, M., Simmons, A., Velayudhan, L., Hye, A., Campbell, J., Zhang, Y., Wahlund, L.-O., Westman, E., Kinsey, A., Güntert, A., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.78 · Cited by 405 · cited 1× · see citing works
“identified as a genetic determinant of AD [217] and plasma CLU levels were associated with atrophy of the entorhinal cortex and clinical progression of the disease [218] as well as with longitudinal brain atrophy in MCI patients [219].”
BackgroundThe Structural Basis of Monoclonal Antibody Alz50's Selectivity for Alzheimer's Disease Pathology
Carmel, G., Mager, E. M., Binder, L. I., & Kuret, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.32789 · Cited by 402 · cited 1× · see citing works
“a conformational change in tau [104], coincides with”
BackgroundCalingasan, N. Y., Uchida, K., & Gibson, G. E. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720751.x · Cited by 400 · see citing works
Smith, M. A., Zhu, X., Tabaton, M., Liu, G., McKeel, D. W., Cohen, M. L., Wang, X., Siedlak, S. L., Dwyer, B. E., Hayashi, T., et al. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1239 · Cited by 400 · cited 1× · see citing works
“Also in preclinical stages and MCI Fe2+ levels were increased in the cortex and cerebellum and correlated with generation of radicals [173].”
BackgroundRegulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase
MacAllister, R. J., Parry, H., Kimoto, M., Ogawa, T., Russell, R. J., Hodson, H. F., Whitley, G. S. J., & Vallance, P. J. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb16069.x · Cited by 394 · cited 1× · see citing works
“This enzyme regulates the activity of nitric oxide synthase [101].”
BackgroundWilliams, T. I., Lynn, B. C., Markesbery, W. R., & Lovell, M. A. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.06.004 · Cited by 391 · cited 1× · see citing works
“and in vivo as a result of lipid peroxidation [76, 77].”
BackgroundOxidative stress increases expression and activity of BACE in NT2 neurons
Tamagno, E., Bardini, P., Obbili, A., Vitali, A., Borghi, R., Zaccheo, D., Pronzato, M. A., Danni, O., Smith, M. A., Perry, G., et al. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0515 · Cited by 385 · see citing works
Schweers, O., Mandelkow, E., Biernat, J., & Mandelkow, E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8463 · Cited by 379 · cited 1× · see citing works
“isoform of tau into such assemblies [107].”
Du Yan, S., Fu, J., Soto, C., Chen, X., Zhu, H., Al-Mohanna, F., Collison, K., Zhu, A., Stern, E., Saido, T., et al. (1997) · Nature · doi:10.1038/39522 · Cited by 379 · see citing works
Zhu, X., Rottkamp, C. A., Boux, H., Takeda, A., Perry, G., & Smith, M. A. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.10.880 · Cited by 378 · cited 2× · see citing works
“be upregulated in AD patient brains [30, 313] and are”
BackgroundButterfield, D. A., Poon, H. F., St. Clair, D., Keller, J. N., Pierce, W. M., Klein, J. B., & Markesbery, W. R. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.11.002 · Cited by 377 · see citing works
Gabuzda, D., Busciglio, J., Chen, L. B., Matsudaira, P., & Yankner, B. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36875-8 · Cited by 373 · cited 1× · see citing works
“Details of A PP 1137 processing have been extensively covered in a number 1138 of reviews [81, 285].”
BackgroundCopper Mediates Dityrosine Cross-Linking of Alzheimer's Amyloid-β
Atwood, C., Perry, G. L., Zeng, H., Kato, Y., Jones, W. D., Ling, K.-Q., Huang, X., Moir, R. D., Wang, D., Sayre, L. M., et al. (2003) · Biochemistry · doi:10.1021/bi0358824 · Cited by 371 · see citing works
Chen, Y., Durakoglugil, M. S., Xian, X., & Herz, J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914984107 · Cited by 368 · cited 1× · see citing works
“The pathogenic origins of ApoE4 have been studied to great length and indicate that ApoE4 is involved in processes such as aggregation and clearance of A [240, 241], mitochondrial dysfunction, and impairment of calcium [242, 243] or cellular iron homeostasis [244], and ApoE4 affects synaptic architecture and functioni…”
BackgroundChanges in the Sleep and Waking EEGs of Nondemented and Demented Elderly Subjects
Prinz, P. N., Peskind, E. R., VITALIANO, P. P., Raskind, M. A., Eisdorfer, C., ZEMCUZNIKOV, H. N., & Gerber, C. J. (1982) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1982.tb01279.x · Cited by 367 · see citing works
Oda, T., Wals, P., Osterburg, H. H., Johnson, S. A., Pasinetti, G. M., Morgan, T. E., Rozovsky, I., Stine, W. B., Snyder, S. W., Holzman, T. F., et al. (1995) · Experimental Neurology · doi:10.1006/exnr.1995.1080 · Cited by 352 · cited 1× · see citing works
“Apart from an antioxidative effect of CLU, an indirect role of CLU actually promoting oxidative stress has been described showing that the presence of CLU induces the formation of slowly sedimenting complexes composed of SDS-resistant synthetic A assemblies that, in turn, induced oxidative stress in PC12 cells [235].”
BackgroundCalcium signaling and molecular mechanisms underlying neurodegenerative diseases
Pchitskaya, E. I., Александровна, П. Е., & Борисович, Б. И. (2017) · Cell Calcium · doi:10.1016/j.ceca.2017.06.008 · Cited by 346 · see citing works
Tamagno, E., Guglielmotto, M., Aragno, M., Borghi, R., Autelli, R., Giliberto, L., Muraca, G., Danni, O., Zhu, X., Smith, M. A., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05072.x · Cited by 338 · see citing works
Transferrin and Iron in Normal, Alzheimer's Disease, and Parkinson's Disease Brain Regions
Loeffler, D. A., Connor, J. R., Juneau, P. L., Snyder, B. S., Kanaley, L., DeMaggio, A. J., Nguyen, H., Brickman, C. M., & LeWitt, P. A. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65020710.x · Cited by 334 · cited 1× · see citing works
“homeostasis has been observed in various neurode699 generative disorders including AD [170].”
BackgroundRukhsana Sultana, A., Debra Boyd-kimball, A., Poon, H. F., Cai, J., Pierce, W. M. J., Klein, J. B., Merchant, M. L., Markesbery, W. R., & Butterfield, D. A. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.021 · Cited by 334 · see citing works
RAGE potentiates Aβ‐induced perturbation of neuronal function in transgenic mice
Arancio, O., Zhang, H. P., Chen, X., Lin, C., Trinchese, F., Puzzo, D., Liu, S., Hegde, A. N., Yan, S. F., Stern, A., et al. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600415 · Cited by 328 · cited 1× · see citing works
“The offspring of a transgenic RAGE overexpressing mouse model crossed with Tg APP animals showed neuronal perturbation already at 3-4 months of age, and astrogliosis and reactive microglia at 14–18 months [428].”
BackgroundMitochondrial permeability transition pore is a potential drug target for neurodegeneration
Rao, V. K., Carlson, E. A., & Yan, S. S. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.09.003 · Cited by 325 · cited 1× · see citing works
“As a result of these observations, various studies embarked on targeting CypD/mPTP inhibition as potential treatment for neurodegenerative diseases [467, 468].”
BackgroundTamagno, E., Parola, M., Bardini, P., Piccini, A., Borghi, R., Guglielmotto, M., Santoro, G., Davit, A., Danni, O., Smith, M. A., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02895.x · Cited by 324 · cited 16× · see citing works
“In human SK-N-BE neuroblastoma cells, which were exposed to HNE- or H2O2mediated oxidative stress, an increase in A level was found that could be attributed indirectly to - secretase in a c-jun N-terminal kinase (JNK)/c-jun pathway/BACE1 dependent manner [75].”
BackgroundInfluentialHatfield, C. F. (2004) · Brain · doi:10.1093/brain/awh129 · Cited by 323 · see citing works
Mitochondrial oxidative stress after carbon monoxide hypoxia in the rat brain.
Zhang, J., & Piantadosi, C. A. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115980 · Cited by 320 · cited 1× · see citing works
“Various conditions have been associated with 839 increased brain oxidative stress and neuronal apop840 tosis in response to hypoxia, including sleep apnea 841 [197, 198], exposure to carbon monoxide [199], and 842 ischemia [200].”
BackgroundChang, S., Ma, T. R., Miranda, R. D., Balestra, M. E., Mahley, R. W., & Huang, Y. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508254102 · Cited by 319 · cited 1× · see citing works
“ance of A [240, 241], mitochondrial dysfunction, 972 and impairment of calcium [242, 243] or cellular 973 iron homeostasis [244], and ApoE4 affects synaptic 974 architecture and functioning [245, 246].”
BackgroundOxidative Stress in Alzheimer’s Disease: Why Did Antioxidant Therapy Fail?
Persson, T., Popescu, B. O., & Cedazo-Mı́nguez, Á. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/427318 · Cited by 318 · see citing works
Nagai, T., Yamada, K., Kim, H., Kim, Y., Noda, Y., Imura, A., Nabeshima, Y., & Nabeshima, T. (2002) · The FASEB Journal · doi:10.1096/fj.02-0448fje · Cited by 312 · cited 1× · see citing works
“Mutation of klotho in a transgenic mouse model demonstrated increased levels of 8-OHdG and malondialdehyde in the hippocampus in an age-dependent manner [356].”
BackgroundMitochondria and Ca2+in cell physiology and pathophysiology
Duchen, M. R. (2000) · Cell Calcium · doi:10.1054/ceca.2000.0170 · Cited by 310 · see citing works
Intermittent Hypoxia Is Associated with Oxidative Stress and Spatial Learning Deficits in the Rat
Row, B. W., Liu, R., Xu, W., Kheirandish, L., & Gozal, D. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200209-1050oc · Cited by 307 · see citing works
Kawakami, K., Scheidereit, C., & Roeder, R. G. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.13.4700 · Cited by 306 · cited 5× · see citing works
“The redox state regulates activation and nuclear translocation of NFκB [180], and, as such, ROS was found to induce phosphorylation of IκB via activation of responsible kinases [181, 182].”
BackgroundInfluentialZou, K., Gong, J.-S., Yanagisawa, K., & Michikawa, M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-12-04833.2002 · Cited by 305 · cited 3× · see citing works
“Supportive of such a hypothesis is the observation that A was found to act as a neurotrophic agent selectively at low nM concentrations while at higher peptide concentrations neurotrophic functionality was abolished [363, 373, 374].”
BackgroundMisonou, H., Morishima-Kawashima, M., & Ihara, Y. (2000) · Biochemistry · doi:10.1021/bi000169p · Cited by 304 · see citing works
Dunn, J. A., McCance, D. R., Thorpe, S. R., Lyons, T. J., & Baynes, J. (1991) · Biochemistry · doi:10.1021/bi00219a007 · Cited by 304 · cited 1× · see citing works
“related [423, 424] and accelerates in conditions such 1760 as diabetes [425].”
BackgroundLiu, R.-Y., Zhou, J.-N., van Heerikhuize, J., Hofman, M. A., & Swaab, D. F. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.1.5394 · Cited by 304 · cited 1× · see citing works
“Even though aging is related 629 to a decrease in CSF melatonin levels, presenile and 630 senile AD patients demonstrated an even stronger 631 reduction in melatonin levels that was shown to be 632 dependent on apolipoprotein genotype [146], one of 633 the strongest identified genetic correlates with AD.”
BackgroundLopez‐Molina, L., Conquet, F., Dubois‐Dauphin, M., & Schibler, U. (1997) · The EMBO Journal · doi:10.1093/emboj/16.22.6762 · Cited by 300 · cited 1× · see citing works
“On the other hand, brain and peripheral tissues were shown to differ in their peroxiredoxin oxidation rhythms [324] as well as in other clock components [325].”
BackgroundKardos, J., Kovács, I., Hajós, F., Kálmán, M., & Simonyi, M. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90565-x · Cited by 298 · cited 1× · see citing works
“inhibiting the rat excitatory NMDA receptor [164], 689 and rat GABA receptor [164, 165].”
Background[Apolipoprotein E polymorphism and Alzheimer disease].
van der Weide, J., Steijns, L. S. W., Jl, T., Wj, N., & Klaverwijden, G. (1996) · PubMed · Cited by 297 · see citing works
Kanninen, K. M., Heikkinen, R., Malm, T., Rõlova, T., Kemppainen, S., Leinonen, H. M., Ylä‐Herttuala, S., Tanila, H., Levonen, A., Koistinaho, M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908397106 · Cited by 293 · cited 5× · see citing works
“Spatial link between amyloid plaques and cells exhibiting oxidative damage A multiphoton microscopy-based study using the genetically encoded calcium indicator Yellow Cameleon 3.6 packaged into an adeno-associated virus (AAV2) and expressed in the brains of adult transgenic APP/PS1 mice showed that calcium overloaded…”
BackgroundInfluentialSavage, M. J., Lin, Y.-G., Ciallella, J. R., Flood, D. G., & Scott, R. W. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03376.2002 · Cited by 291 · cited 1× · see citing works
“Pre1197 treatment of these NT2 cells with -tocopherol 1198 prevented BACE induction and CTF generation 1199 demonstrating direct involvement of oxidative stress 1200 in inducing BACE activity [81, 297].”
BackgroundAtamna, H., & Boyle, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600134103 · Cited by 291 · see citing works
Walter, P. B., Fung, E. B., Killilea, D. W., Jiang, Q., Hudes, M. L., Madden, J., Porter, J. B., Evans, P., Vichinsky, E. P., & Harmatz, P. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06277.x · Cited by 288 · cited 1× · see citing works
“myocardial infarction [18], sickle cell disease [19],”
Role of RAGE in Alzheimer’s Disease
Cai, Z., Liu, N., Wang, C., Qin, B., Zhou, Y., Xiao, M., Chang, L., Yan, L., & Zhao, B. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0233-3 · Cited by 286 · cited 1× · see citing works
“The roles of RAGE and AGEs in AD pathogenesis have been covered in a number of reviews [426, 427].”
BackgroundJacobs, K. M., Pennington, J. D., Bisht, K. S., Aykin‐Burns, N., Kim, H., Mishra, M. V., Sun, L., Nguyen, P., Ahn, B., Leclerc, J., et al. (2008) · International Journal of Biological Sciences · doi:10.7150/ijbs.4.291 · Cited by 281 · cited 1× · see citing works
“NAD+-dependent deacetylase SirT3 is an important regulator of energy production and redox response by reduction of GSH [331, 332], mediating the upregulation of SOD2 and catalase [333], and activation of SOD2 [334].”
BackgroundMechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer’s disease
Atamna, H., & Frey, W. H. (2007) · Mitochondrion · doi:10.1016/j.mito.2007.06.001 · Cited by 278 · cited 1× · see citing works
“is significantly decreased in the AD brain [87].”
BackgroundIncreased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice
Li, F., Calingasan, N. Y., Yu, F., Mauck, W. M., Toidze, M., Almeida, C. G., Takahashi, R. H., Carlson, G. A., Beal, M. F., Lin, M. T. S., et al. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02455.x · Cited by 276 · see citing works
Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment
Markesbery, W. R., Kryscio, R. J., Lovell, M. A., & Morrow, J. D. (2005) · Annals of Neurology · doi:10.1002/ana.20629 · Cited by 272 · cited 1× · see citing works
“809 Consistent with this, an earlier longitudinal study on 810 autopsied control and patient brains demonstrated 811 that levels of isoprostane (F2) and F4-neuroprostane 812 were increased in both amnestic MCI and late stage 813 AD patients in various regions of the brain [189].”
ResultAntioxidant clinical trials in mild cognitive impairment and Alzheimer's disease
Mecocci, P., & Polidori, M. C. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.006 · Cited by 270 · see citing works
Giraldo, E., Lloret, A., Fuchsberger, T., & Viña, J. (2014) · Redox Biology · doi:10.1016/j.redox.2014.03.002 · Cited by 268 · see citing works
Flagged first, then by citations
4 of the 475 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Juan, C. A., Pérez de la Lastra, J. M., Plou, F. J., & Pérez-Lebeña, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094642 · Cited by 2,810 · see citing works
“In Huntington’s disease, the mutant huntingtin protein causes mitochondrial dysfunction, with higher levels of ROS and increased oxidative stress [33].”
BackgroundNrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease
Ngo, V., & Duennwald, M. L. (2022) · Antioxidants · doi:10.3390/antiox11122345 · Cited by 1,130 · see citing works
“Oxidative damage has been implicated in all major neurodegenerative diseases including Alzheimer’s disease (AD) [108,109], Parkinson’s disease (PD) [110,111], Huntington’s disease (HD) [112,113], amyotrophic lateral sclerosis (ALS) [114], and multiple sclerosis (MS) [115].”
BackgroundAn Overview of Oxidative Stress, Neuroinflammation, and Neurodegenerative Diseases
Teleanu, D. M., Niculescu, A.-G., Lungu, I. I., Radu, C. I., Vladâcenco, O., Roza, E., Costăchescu, B., Grumezescu, A. M., & Teleanu, R. I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115938 · Cited by 1,085 · see citing works
“HNE can be detected at the early stages of AD progress, while its levels have been reported to be proportional to the extent of neuronal lesions [47].”
BackgroundJurcău, M. C., Andronie-Cioara, F. L., Jurcău, A., Marcu, F., Ţiț, D. M., Pașcalău, N., & Nistor-Cseppentö, D. C. (2022) · Antioxidants · doi:10.3390/antiox11112167 · Cited by 226 · see citing works
“With aging, cerebral glucose metabolism progressively declines as a result of changes in brain insulin and cortisol levels [46] and of decreased activity of synaptic ATPases [47], leading to a 45% reduced cerebral glucose utilization [46].”
BackgroundThe Role of Oxidative Stress and Natural Antioxidants in Ovarian Aging
Yang, L., Chen, Y., Liu, Y., Xing, Y., Miao, C., Zhao, Y., Chang, X., & Zhang, Q. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.617843 · Cited by 231 · see citing works
Role of reactive oxygen species in the progression of Alzheimer’s disease
Bhatt, S., Puli, L., & Patil, C. R. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.12.004 · Cited by 207 · see citing works
Roy, R. G., Mandal, P. K., & Maroon, J. C. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00486 · Cited by 194 · see citing works
Alzheimer's Disease Puzzle: Delving into Pathogenesis Hypotheses
(2024) · aging and disease · doi:10.14336/ad.2023.0608 · Cited by 183 · see citing works
“Oxidative stress in the cortex and hippocampal tissues is a common characteristic of AD [145].”
BackgroundMolecular Mechanisms of Neuroinflammation in Aging and Alzheimer’s Disease Progression
Andronie-Cioară, F. L., Ardelean, A. I., Nistor-Cseppento, C. D., Jurcău, A., Jurcău, M. C., Pașcalău, N., & Marcu, F. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24031869 · Cited by 164 · see citing works
Michalska, P., & Leon, R. M. (2020) · Antioxidants · doi:10.3390/antiox9080740 · Cited by 112 · see citing works
Potential Roles of Redox Dysregulation in the Development of Schizophrenia
Perkins, D. O., Jeffries, C. D., & Do, K. Q. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.03.016 · Cited by 103 · see citing works
Axonal Degeneration in AD: The Contribution of Aβ and Tau
Salvadores, N., Gerónimo‐Olvera, C., & Court, F. A. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.581767 · Cited by 97 · see citing works
“In the context of AD, different pathogenic pathways have been shown to contribute to axon demise, including calcium signaling imbalance, mitochondrial dysfunction, alterations in axonal transport, and increased oxidative stress (Bamburg and Bloom, 2009; Yu et al., 2009; Ye et al., 2012; Cioffi et al., 2019; Guo et al.…”
BackgroundHarnessing endophenotypes and network medicine for Alzheimer's drug repurposing
Fang, J., Pieper, A. A., Nussinov, R., Lee, G., Bekris, L. M., Leverenz, J. B., Cummings, J. L., & Cheng, F. (2020) · Medicinal Research Reviews · doi:10.1002/med.21709 · Cited by 93 · see citing works
“The detailed molecular mechanisms and genetics of oxidative stress in AD were comprehensive described in a previous Review.55 Proteostasis refers to the dysfunction in protein homeostasis, leading to the accumulation of protein aggregates.56 Targeting endoplasmic reticulum acetylation to improve proteostasis in the se…”
BackgroundLi, Z., Liu, Q., Xu, Z., Guo, X., & Wu, S. (2020) · Environmental Research · doi:10.1016/j.envres.2020.110105 · Cited by 92 · see citing works
Cognitive disorder and dementia in type 2 diabetes mellitus
Ortíz, G. G., Huerta, M., González-Usigli, H., Torres-Sánchez, E. D., Delgado-Lara, D. L. C., Pacheco-Moisés, F. P., Mireles-Ramírez, M. A., Torres-Mendoza, B. M., Moreno-Cih, R. I., & Velázquez-Brizuela, I. E. (2022) · World Journal of Diabetes · doi:10.4239/wjd.v13.i4.319 · Cited by 90 · see citing works
Oxygen metabolism abnormality and Alzheimer's disease: An update
Liu, G., Yang, C., Wang, X., Chen, X., Wang, Y., & Le, W. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102955 · Cited by 85 · see citing works
“Chronic hypoxia can upregulate NOX in AD, potentially leading to an increase in O 2 - [ • Excessive ROS can impair mitochondrial function, which can further promote ROS generation, thereby promoting the progression of AD [85].”
BackgroundRedox changes and cellular senescence in Alzheimer's disease
Yu, N., Pasha, M., & Chua, J. J. E. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103048 · Cited by 80 · see citing works
Ağagündüz, D., Bingöl, F. G., Çelik, E., Cemali, Ö., Özenir, Ç., Özoğul, F., & Capasso, R. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03609-y · Cited by 79 · see citing works
“In addition, an increase in reactive oxygen strain is associated with an increase in the oxidation of DNA, proteins, and lipids [93, 94].”
BackgroundMeng, K., Jia, H., Hou, X., Zhu, Z., Lu, Y., Feng, Y., Feng, J., Xia, Y., Tan, R., Cui, F., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13020327 · Cited by 80 · see citing works
“Similarly, the antioxidant capacity of ALS mice is impaired, and the level of ROS in the spinal cord is significantly increased, leading to DNA damage, lipid oxidation, protein oxidation and aggregation, inflammatory response, and apoptosis [110,111].”
The Role of the Transcription Factor Nrf2 in Alzheimer’s Disease: Therapeutic Opportunities
Plano, L. M. D., Calabrese, G., Rizzo, M. G., Oddo, S., & Caccamo, A. (2023) · Biomolecules · doi:10.3390/biom13030549 · Cited by 78 · see citing works
“Under physiological conditions, an increase in ROS stimulates cells to produce a series of antioxidant molecules to prevent oxidative damage [10].”
BackgroundBrain metabolism in Alzheimer’s disease: biological mechanisms of exercise
Xu, L., Liu, R., Qin, Y., & Wang, T. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00364-y · Cited by 78 · see citing works
“Excessive oxidative stress [153], metabolic disturbances [154] and neuroinflammation [155] in the brain mediate the accumulation of abnormal proteins in the context of AD.”
BackgroundPotential use of antioxidants for the treatment of chronic inflammatory diseases
Blagov, A. V., Summerhill, V. I., Sukhorukov, V. N., Zhigmitova, E. B., Postnov, A. Y., & Orekhov, A. N. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1378335 · Cited by 72 · see citing works
Tan, M. S., Cheah, P., Chin, A., Looi, L., & Chang, S. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104947 · Cited by 64 · see citing works
Geigenmüller, J. N., Tari, A. R., Wisløff, U., & Walker, T. L. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14179 · Cited by 64 · see citing works
“114 In a study using post mortem tissue of AD patients, Cruz-Sánchez et al. showed that the AD hippocampus is characterized by elevated markers of oxidative stress.”
Salivary gland dysfunction and salivary redox imbalance in patients with Alzheimer’s disease
Zalewska, A., Klimiuk, A., Zięba, S., Wnorowska, O., Rusak, M., Waszkiewicz, N., Szarmach, I. J., Dzierżanowski, K., & Maciejczyk, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-03456-9 · Cited by 56 · see citing works
Effects and mechanisms of natural products on Alzheimer’s disease
Yang, Z., Zhou, D.-D., Huang, S., Fang, A., Li, H., & Zhu, H. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1985428 · Cited by 59 · see citing works
“Oxidative stress interconnects with Aβ deposition, tau hyperphosphorylation, and loss of synapses and neurons (Cioffi, Adam, and Broersen 2019; Zhao and Zhao 2013).”
BackgroundAntognoni, F., Potente, G., Mandrioli, R., Angeloni, C., Freschi, M., Malaguti, M., Hrelia, S., Lugli, S., Gennari, F., Muzzi, E., et al. (2020) · Antioxidants · doi:10.3390/antiox9080677 · Cited by 55 · see citing works
“Strong evidence suggests that oxidative stress plays a key role in important neurodegenerative syndromes, such as Parkinson’s [22] and Alzheimer’s diseases [23].”
BackgroundRedox Homeostasis and Prospects for Therapeutic Targeting in Neurodegenerative Disorders
Akanji, M. A., Rotimi, D. E., Elebiyo, T. C., Awakan, O. J., & Adeyemı, O. S. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9971885 · Cited by 52 · see citing works
“of guanosine bases to 8-hydroxyguanosine, in brain regions that coordinate cognitive and emotional functions has also been documented [95].”
BackgroundJabir, N. R., Shakil, S., Tabrez, S. S. M., Khan, M. S., Rehman, M. T., & Ahmed, A. B. A. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1784796 · Cited by 52 · see citing works
“The formation and accumulation of amyloid fibers, intracellular neurofibrillary tangles, inflammation, oxidative stress, iron dysregulation and ultimate destruction of the functional activities of neurons are some of the mechanisms of AD (Aliev et al., 2014; Cioffi et al., 2019).”
BackgroundChen, N., Wang, J., He, Y., Xu, Y., Zhang, Y., Gong, Q., Yu, C., & Gao, J. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00584 · Cited by 49 · see citing works
Chu, F., Li, K., Li, X., Xu, L., Huang, J., & Yang, Z. R. (2020) · Neurochemical Research · doi:10.1007/s11064-020-03167-z · Cited by 49 · see citing works
Oxidative Stress: Pathological Driver in Chronic Neurodegenerative Diseases
Chong, Z. Z., & Souayah, N. (2025) · Antioxidants · doi:10.3390/antiox14060696 · Cited by 50 · see citing works
Zubčić, K., Radovanović, V., Vlainić, J., Hof, P. R., Oršolić, N., Šimić, G., & Jembrek, M. J. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/9834742 · Cited by 46 · see citing works
“Cu binding to Aβ increases its ability to form ubiquitin-containing aggregates and greatly promotes Aβ-induced generation of ROS [10, 14, 15].”
BackgroundNguyen, C. D., & Lee, G. (2021) · Antioxidants · doi:10.3390/antiox10111654 · Cited by 46 · see citing works
“This is considered a major cause of the onset of cognitive dysfunction [12,13,39].”
Background(2020) · Letters in Applied NanoBioScience · doi:10.33263/lianbs102.20852095 · Cited by 41 · see citing works
“Oxidative stress has likewise been implicated in several disease conditions, including malignant growth [24], neurodegenerative sicknesses such as Alzheimer’s [25], Parkinson's [26], Huntington [27], amyotrophic lateral sclerosis [28], diabetes [29], ulcer [30], among others.”
BackgroundMultiple chemical sensitivity: It's time to catch up to the science
Molot, J., Sears, M., & Anisman, H. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105227 · Cited by 40 · see citing works
Brain organoids: A promising model to assess oxidative stress‐induced central nervous system damage
Oyefeso, F. A., Muotri, A. R., Wilson, C. G., & Pecaut, M. J. (2021) · Developmental Neurobiology · doi:10.1002/dneu.22828 · Cited by 44 · see citing works
“Protein aggregates are known risk factors repeatedly identified in patients with neurodegenerative diseases, although the mechanisms by which they contribute to these diseases are not fully understood (Cioffi et al., 2019; Olivares et al., 2009).”
BackgroundMorales, L. G. F., Correa‐Basurto, J., & Rosales‐Hernández, M. C. (2021) · Antioxidants · doi:10.3390/antiox10020218 · Cited by 38 · see citing works
“Alzheimer’s disease (AD) is a neurodegenerative disease characterized by memory loss due to multiple factors, including the generation of reactive oxygen species (ROS) [1,2].”
BackgroundTalebi, M., Kakouri, E., Talebi, M., Tarantilis, P. Α., Farkhondeh, T., İlgün, S., Pourbagher‐Shahri, A. M., & Samarghandian, S. (2021) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2021.1923479 · Cited by 39 · see citing works
“Oxidative stress seems to play a crucial role in the pathogenesis of AD [22,23].”
BackgroundMa, L., Jiang, X., Huang, Q.-Y., Chen, W., Zhang, H., Pei, H., Cao, Y., Wang, H., & Li, H. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115244 · Cited by 38 · see citing works
Klotho Pathways, Myelination Disorders, Neurodegenerative Diseases, and Epigenetic Drugs
Moos, W. H., Faller, D. V., Glavas, I. P., Harpp, D. N., Kanara, I., Mavrakis, A. N., Pernokas, J., Pernokas, M., Pinkert, C. A., Powers, W. R., et al. (2020) · BioResearch open access · doi:10.1089/biores.2020.0004 · Cited by 36 · see citing works
Oli, V., Gupta, R. V., & Kumar, P. (2021) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2021.102012 · Cited by 36 · see citing works
Guo, M., Du, C., Li, B., Yao, R., Tang, Y., Jiang, Y., Liu, H., Su, H., Zhou, Y., Wang, L., et al. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.149248 · Cited by 35 · see citing works
“An increasing number of studies have shown that increased oxidative stress is a potential biological pathway behind the adverse health effects of ambient PM on cardiovascular health, respiratory health and nervous system health (Cioffi et al. 2019; Hecker 2018; Rao et al. 2018).”
BackgroundPomegranate (Punica granatum L.) Extract Effects on Inflammaging
Cordiano, R., Gammeri, L., Salvo, E. D., Gangemi, S., & Minciullo, P. L. (2024) · Molecules · doi:10.3390/molecules29174174 · Cited by 38 · see citing works
Karimani, A., Ramezani, N., Goli, A. A., Shirazi, M. H. N., Nourani, H., & Jafari, A. M. (2021) · Toxicology Reports · doi:10.1016/j.toxrep.2021.06.017 · Cited by 33 · see citing works
Söderbom, G., & Zeng, B. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.03.023 · Cited by 31 · see citing works
Merighi, S., Battistello, E., Casetta, I., Gragnaniello, D., Poloni, T. E., Medici, V., Cirrincione, A., Varani, K., Vincenzi, F., Borea, P. A., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201437 · Cited by 32 · see citing works
“Notably, the abnormal accumulation of A (cid:2) is responsible for important detrimental effects, including oxidative stress injury, which then results in neuronal death [56].”
Yamini, P., Ray, R. S., Yadav, S., Dhaliwal, J., Yadav, M., Kondepudi, K. K., & Chopra, K. (2022) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2022.173402 · Cited by 31 · see citing works
Wang, X., Li, H., Sheng, Y., He, B., Liu, Z., Li, W., Yu, S., Wang, J., Zhang, Y., Chen, J., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.116071 · Cited by 29 · see citing works
Anticancer Activity of Astaxanthin-Incorporated Chitosan Nanoparticles
Hwang, E. J., Jeong, Y., Lee, K.-J., Yu, Y.-B., Ohk, S., & Lee, S. (2024) · Molecules · doi:10.3390/molecules29020529 · Cited by 28 · see citing works
“For example, oxidative stress has a deep relationship with the progress of Alzheimer’s disease and then aggravates its symptoms [37–39].”
BackgroundKamath, A. P., Nayak, P. G., John, J., Mutalik, S., Balaraman, A. K., & Nandakumar, K. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110096 · Cited by 29 · see citing works
“It has been shown that oxidative stress plays a significant role in the development of AD (Cioffi et al., 2019).”
BackgroundDrosophila as a model to explore secondary injury cascades after traumatic brain injury
Buhlman, L. M., Krishna, G., Jones, T. B., & Thomas, T. C. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112079 · Cited by 28 · see citing works
Potential of food-derived bioactive peptides in alleviation and prevention of Alzheimer's disease
Zhao, L., Li, D., Qi, X., Guan, K., Chen, H., Wang, R., & Ma, Y. (2022) · Food & Function · doi:10.1039/d2fo02278h · Cited by 29 · see citing works
Denéchaud, M., Geurs, S., Comptdaer, T., Bégard, S., García-Núñez, A., Pechereau, L.-A., Bouillet, T., Vermeiren, Y., de Deyn, P., Perbet, R., et al. (2022) · Progress in neurobiology · doi:10.1016/j.pneurobio.2022.102386 · Cited by 28 · see citing works
Orioli, R., Belluti, F., Gobbi, S., Rampa, A., & Bisi, A. (2024) · Molecules · doi:10.3390/molecules29153514 · Cited by 28 · see citing works
Zhang, Y., Bi, K., Zhou, L., Wang, J., Huang, L., Sun, Y., Peng, G., & Wu, W. (2024) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s471174 · Cited by 28 · see citing works
“37 In preclinical AD models and AD patients, elevated levels of oxidative stress biomarkers such as 4-hydroxy-2-nonenal (HNE), F2-isoprostanes, and F4-isoprostanes have been observed.”
BackgroundNaik, R. A., Mir, M. N., Malik, I. A., Bhardwaj, R., Alshabrmi, F. M., Mahmoud, M. A., Alhomrani, M., Alamri, A. S., Alsanie, W. F., Hjazi, A. M., et al. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl25551 · Cited by 28 · see citing works
Salzer, L., & Witting, M. A. (2021) · Metabolites · doi:10.3390/metabo11050284 · Cited by 28 · see citing works
Metabolic reprogramming in the arsenic carcinogenesis
Ruan, Y., Fang, X. H., Guo, T., Liu, Y., Hu, Y., Wang, X., Hu, Y., Gao, L., Li, Y., Pi, J., et al. (2021) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2021.113098 · Cited by 28 · see citing works
Fuentes‐Medel, E., Venegas, B., Muñoz‐Arenas, G., Morán, C., Vázquez‐Roque, R. A., Flores, G., Treviño, S., Díaz, A., & Guevara, J. (2023) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2023.102237 · Cited by 28 · see citing works
Potential Retinal Biomarkers in Alzheimer’s Disease
García-Bermúdez, M. Y., Vohra, R., Freude, K., van Wijngaarden, P., Martin, K. R. G., Thomsen, M. S., Aldana, B. I., & Kolko, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115834 · Cited by 30 · see citing works
From Brain to Muscle: The Role of Muscle Tissue in Neurodegenerative Disorders
Duranti, E., & Villa, C. (2024) · Biology · doi:10.3390/biology13090719 · Cited by 29 · see citing works
He, J., Liu, F., Xu, T., Ma, J., Yu, H., Zhao, J., Xie, Y., Luo, L., Yang, Q., Lou, T., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115807 · Cited by 28 · see citing works
Sivapackiam, J., Liao, F., Zhou, D., Shoghi, K. I., Gropler, R. J., Gelman, A. E., & Sharma, V. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101690 · Cited by 25 · see citing works
“Noticeably, this imbalance in production/mitigation of ROS has been implicated in the pathogenesis of numerous diseases, such as cardiovascular disease [10], diabetes [11], atherosclerosis [12], asthma [13], Alzheimer’s disease [14], psoriasis [15], rheumatoid arthritis”
BackgroundXian, T., Liu, Y., Ye, Y., Peng, B., Huang, J., Liang, L., Zhang, J., Wu, H. B., & Lin, Z. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.09.046 · Cited by 25 · see citing works
CRISPR/Cas9 and iPSC-Based Therapeutic Approaches in Alzheimer’s Disease
Raffaele, I., Cipriano, G. L., Anchesi, I., Oddo, S., & Silvestro, S. (2025) · Antioxidants · doi:10.3390/antiox14070781 · Cited by 25 · see citing works
“Several molecular mechanisms have been described in which oxidative stress and the two hallmark proteins, A β and tau, could be associated, creating a vicious cycle that accelerates disease progression, impairing neural and cognitive function [35].”
Amyloid-β 25-35 Induces Neurotoxicity through the Up-Regulation of Astrocytic System Xc−
D’Ezio, V., Colasanti, M., & Persichini, T. (2021) · Antioxidants · doi:10.3390/antiox10111685 · Cited by 25 · see citing works
“Most of the known genetic, medical, environmental, and lifestyle-related risk factors for AD are associated with increased oxidative stress [10,11].”
BackgroundMaria, C., & Rauter, A. P. (2023) · Carbohydrate Research · doi:10.1016/j.carres.2023.108889 · Cited by 25 · see citing works
Bilirubin and Redox Stress in Age-Related Brain Diseases
Llido, J. P., Jayanti, S. D., Tiribelli, C., & Gazzin, S. (2023) · Antioxidants · doi:10.3390/antiox12081525 · Cited by 25 · see citing works
Chemistry and biology of natural stilbenes: an update
Zhou, L., Cai, X., Wang, Y., Yang, J., Wang, Y.-D., Deng, J., Ye, D., Zhang, L., Liu, Y., & Ma, S.-C. (2024) · Natural Product Reports · doi:10.1039/d4np00033a · Cited by 23 · see citing works
Nrf2/Bach1 signaling axis: A promising multifaceted therapeutic strategy for Alzheimer's disease
Soni, P., Sharma, S. M., Pieper, A. A., Paul, B. D., & Thomas, B. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00586 · Cited by 22 · see citing works
“While signi fi cant advances have been made in understanding the molecular underpinnings of AD, oxidative stress has emerged as a pivotal driver of disease progression, contributing to neuronal dysfunction and degeneration [8,9].”
Xiao, X., Yan, X., Liang, C., & Yang, Y. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1772036 · Cited by 23 · see citing works
Tampio, J., Huttunen, J., Montaser, A. B., & Huttunen, K. M. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02045-7 · Cited by 22 · see citing works
Han, J., Zhang, H., Zhang, Y., Zhang, Z., Yu, M., Wang, S., & Han, F. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115194 · Cited by 22 · see citing works
Deshpande, P., Gogia, N., Chimata, A. V., & Singh, A. (2021) · BioTechniques · doi:10.2144/btn-2021-0006 · Cited by 21 · see citing works
“This increased oxidative stress due to increased ROS levels results in modification of biomolecules and other compounds in tissue, and is associated with AD pathology [16].”
Moliner, C., Cásedas, G., Barros, L., Finimundy, T. C., Rincón, C. G., & López, V. (2022) · Antioxidants · doi:10.3390/antiox11071244 · Cited by 21 · see citing works
“Experimental and clinical evidence suggests that oxidative stress plays a crucial role in the pathogenesis of Alzheimer’s disease and other neurogenerative disorders [37,38].”
BackgroundApolipoprotein E ε4 modulates astrocyte neuronal support functions in the presence of amyloid‐β
Fleeman, R. M., Kuhn, M. K., Chan, D. C., & Proctor, E. A. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15781 · Cited by 20 · see citing works
“This finding may potentially explain increased oxidative stress observed in the brains of human APOE4 carriers (Butterfield & Mattson, 2020; Cioffi et al., 2019; Tönnies & Trushina, 2017).”
BackgroundSarlaki, F., Shahsavari, Z., Goshadrou, F., Naseri, F., Keimasi, M., & Sirati‐Sabet, M. (2022) · Biomedicine · doi:10.37796/2211-8039.1341 · Cited by 20 · see citing works
“However, none of these hypotheses completely explain the molecular mechanisms responsible for the source of oxidative stress [52,53].”
BackgroundInnovative pathological network‐based multitarget approaches for Alzheimer's disease treatment
Mayo, P., Pascual-Guerra, J., Crisman, E., Domínguez, C., López, M. G., & Leon, R. M. (2024) · Medicinal Research Reviews · doi:10.1002/med.22045 · Cited by 19 · see citing works
Saeed, K. M., Shah, S. A., Ullah, R., Alam, S. I., Park, J. S., Saleem, S., Jo, M. H., Kim, M. W., Hahm, J. R., & Kim, M. O. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/9523758 · Cited by 20 · see citing works
“However, in stress condition, the endogenous antioxidant activity of the Keap1/Nrf2 pathway is compromised leading to reduced ARE-mediated transcription of phase II enzymes including GST, NAD(P)H : quinone oxidoreductase (NQO-1), and UDP-glucuronosyl transferase (UGT) and other detoxifying antioxidant genes like HO-1…”
BackgroundRetractedLi, H., Gao, J., Chang, Y., Li, K., Wang, L., Ju, C., & Zhang, F. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107726 · Cited by 19 · see citing works
Stein, J., Walkenfort, B., Cihankaya, H., Hasenberg, M., Bader, V., Winklhofer, K. F., Röderer, P., Matschke, J., Theiß, C., & Matschke, V. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6924251 · Cited by 19 · see citing works
“An elevated ROS level in the spinal cord of wob-bler mice could lead to DNA damage, lipid oxidation, protein oxidation and aggregation, induction of in fl ammatory processes, excitotoxicity, reduction in the e ffi ciency of cellular process, and apoptosis [20, 60, 61].”
BackgroundCopper(II), Nickel(II) and Zinc(II) Complexes of Peptide Fragments of Tau Protein
Kastal, Z., Balabán, A., Vida, S., Kállay, C., Nagy, L., Várnagy, K., & Sóvágó, I. (2024) · Molecules · doi:10.3390/molecules29102171 · Cited by 18 · see citing works
“According to a literature review and clinical observations, oxidative stress is suggested as the dominant factor for the pathogenesis of Alzheimer’s disease [18,19].”
BackgroundHelmer, P. O., Nicolai, M. M., Schwantes, V., Bornhorst, J., & Hayen, H. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.10.019 · Cited by 19 · see citing works
Mohammed, R. A., & Mansour, S. M. (2021) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgaa072 · Cited by 19 · see citing works
Zhang, K., Wang, J., & Xu, B. (2025) · Antioxidants · doi:10.3390/antiox14080904 · Cited by 18 · see citing works
“For instance, plaque aggregation and the high phosphorylation of tau, induced by oxidative stress, are two of the main causes of AD [4].”
Wigner, P., Dziedzic, A., Synowiec, E., Miller, E. D., Bijak, M., & Saluk, J. (2022) · Scientific Reports · doi:10.1038/s41598-022-14795-6 · Cited by 20 · see citing works
Maghsoudi, A. S., Hassani, S., Zarerad, E., Niksalehi, K., Armandeh, M., Sani, M. A., Ataei, M., & Mousavi, T. (2022) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557523666221213091445 · Cited by 18 · see citing works
HEBP1 - An early trigger for neuronal cell death and circuit dysfunction in Alzheimer’s disease
Chua, J. J. E. (2022) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2022.07.005 · Cited by 18 · see citing works
Cowan, C. M., Sealey, M. A., & Mudher, A. K. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15253 · Cited by 17 · see citing works
Somatic Mutations and Alzheimer’s Disease
Downey, J., Lam, J. C. K., Li, V. O. K., & Gozes, I. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220643 · Cited by 17 · see citing works
Potential Benefits of Anthocyanins in Chronic Disorders of the Central Nervous System
Panchal, S. K., & Brown, L. (2022) · Molecules · doi:10.3390/molecules28010080 · Cited by 17 · see citing works
Testa, G., Giannelli, S., Sottero, B., Staurenghi, E., Giaccone, G., Caroppo, P., Gamba, P., & Leonarduzzi, G. (2023) · Antioxidants · doi:10.3390/antiox12030631 · Cited by 18 · see citing works
Lee, Y., Park, M.-C., Jeong, S. H., Kang, S. W., Baik, K., Jung, J. H., Lee, P. H., Sohn, Y. H., & Ye, B. S. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.05.003 · Cited by 16 · see citing works
Campos-Prieto, L., García-Rey, A., Sotelo, E., & Mallo‐Abreu, A. (2024) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.20.261 · Cited by 16 · see citing works
Wang, Y., & Liu, X. (2023) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2023/9935942 · Cited by 15 · see citing works
RetractedYing, N., Luo, H., Li, B.-X., Gong, K.-Y., Shu, Q., Liang, F., Gao, H., Huang, T., & Zheng, H. (2023) · Journal of Proteome Research · doi:10.1021/acs.jproteome.2c00691 · Cited by 14 · see citing works
Deshpande, P., Chen, C., Chimata, A. V., Li, J., Sarkar, A., Yeates, C. J., Chen, C., Kango‐Singh, M., & Singh, A. (2024) · Cell Death and Disease · doi:10.1038/s41419-023-06361-3 · Cited by 14 · see citing works
“Scale bar = 50 μ m. oxidative modi fi cation of biomolecules in postmitotic neurons are associated with AD pathology [58, 70, 71].”
BackgroundMultifunctional Fluorescent Probes Unveiling Complex Pathways in Alzheimer’s Disease Pathogenesis
Ghosh, P., & Iyer, P. K. (2024) · Accounts of Materials Research · doi:10.1021/accountsmr.4c00303 · Cited by 14 · see citing works
Piccirillo, S., Preziuso, A., Amoroso, S., Serfilippi, T., Miceli, F., Magi, S., & Lariccia, V. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01187-y · Cited by 13 · see citing works
“All the above-mentioned events lead to less efficient production of ATP and, at the same time, shift the balance toward pro-oxidant activities [10, 11].”
Background
- Authors
- Cioffi, F., Adam, R. H. I., & Broersen, K.
- Affiliations
- University of Twente (NL)
- Corresponding author
- Broersen, Kerensa
- ORCID
- Broersen, Kerensa
- Venue
- Journal of Alzheimer s Disease
- Publisher
- SAGE Publications
- Published
- 2019-12-12
- Volume
- 72
- Issue
- 4
- Pages
- 981-1017
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- PMC
- PMC6971833
- OpenAlex
- W2984421981
- Cited by
- 204
- References
- 475
- Citations by year
- 2026: 17 · 2025: 30 · 2024: 36 · 2023: 36 · 2022: 28 · 2021: 36 · 2020: 21
- FWCI
- 2.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Alzheimer s Disease (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- University of Twente Research Information (submittedVersion, cc-by-nc)
- Funders
- ZonMw (733050304)
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- Alzheimer's disease, oxidative stress
- MeSH terms
- Alzheimer Disease, Animals, Brain, Humans, Amyloid beta-Peptides, tau Proteins, Reactive Oxygen Species, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review